Policy and Legislation
Assemblymember David Chiu (D-San Francisco) has introduced a bill that would strengthen intra-agency collaboration on drug cost-saving strategies.
Dr. Brett Giroir, who is currently CEO of biopharmaceutical company ViraCyte, takes over role formerly held by Karen DeSalvo.
Insurers operating in states granted waivers would also be able to charge high risk consumers more for premiums.
Spending bloat, "patchwork" regulations, unstable markets are a problem for reform efforts, experts said.
Before the ACA, states had differing approaches to handling preexisting conditions.
As in other heated meetings, audience members held up red signs when they disagreed with Jordan and, less frequently, green signs when they agreed.
As Republicans eye healthcare reform, Congress must soon decide whether to extend CHIP when its funding ends in September.
Clinicians should participate in MIPS for 2017 transition year if they bill more than $30,000 in Medicare Part B allowed charges a year, CMS said.
On average, insurers remaining in ACA market would need to increase silver plan premiums by 19 percent to make up that gap.
Alaska and Minnesota have seen double-digit increases in ACA plan premiums this year have already moved to implement reinsurance policies.